The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens
At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaquiline and delamanid was a critical deve...
Source: BMC Infectious Diseases - Category: Infectious Diseases Authors: Uzma Khan, Helena Huerga, Aamir J. Khan, Carole D. Mitnick, Catherine Hewison, Francis Varaine, Mathieu Bastard, Michael Rich, Molly F. Franke, Sidney Atwood, Palwasha Y. Khan and Kwonjune J. Seung Tags: Study protocol Source Type: research
More News: Bedaquiline | Infectious Diseases | Marketing | Multidrug Resistance | Study | Tuberculosis